Stryker Corp
SYK353.710USD
-0.380-0.11%
Market hours （ET）Quotes delayed by 15 min
135.26BMarket Cap
45.91P/E TTM
More Details of Stryker Corp Company
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Stryker Corp Info
Ticker SymbolSYK
Company nameStryker Corp
IPO dateMar 17, 1980
CEOLobo (Kevin A)
Number of employees53000
Security typeOrdinary Share
Fiscal year-endMar 17
Address1941 Stryker Way
CityPORTAGE
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code49002
Phone12693852600
Websitehttps://www.stryker.com/
Ticker SymbolSYK
IPO dateMar 17, 1980
CEOLobo (Kevin A)
Company Executives of Stryker Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.90K
+1.24%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
12.69K
-3.79%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
8.15K
-21.45%
Mr. Preston W. Wells
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
6.68K
-7.84%
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
6.38K
+9.63%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.78K
+10.74%
Dr. Giovanni Caforio, M.D.
Dr. Giovanni Caforio, M.D.
Independent Director
Independent Director
2.80K
+25.01%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.90K
+1.24%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
12.69K
-3.79%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
8.15K
-21.45%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Medical
990.00M
16.44%
Trauma and Extremities
957.00M
15.89%
Endoscopy
899.00M
14.93%
Instruments
768.00M
12.75%
Knees
640.00M
10.63%
Other
1.77B
29.36%
By RegionUSD
Name
Revenue
Proportion
United States
4.55B
75.62%
International
1.47B
24.38%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Medical
990.00M
16.44%
Trauma and Extremities
957.00M
15.89%
Endoscopy
899.00M
14.93%
Instruments
768.00M
12.75%
Knees
640.00M
10.63%
Other
1.77B
29.36%
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.79%
Brown (John W)
5.24%
Greenleaf Trust
4.35%
BlackRock Institutional Trust Company, N.A.
4.25%
State Street Investment Management (US)
3.91%
Other
73.45%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.79%
Brown (John W)
5.24%
Greenleaf Trust
4.35%
BlackRock Institutional Trust Company, N.A.
4.25%
State Street Investment Management (US)
3.91%
Other
73.45%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.41%
Investment Advisor/Hedge Fund
21.89%
Bank and Trust
6.61%
Individual Investor
5.36%
Research Firm
3.31%
Pension Fund
2.04%
Sovereign Wealth Fund
1.31%
Hedge Fund
1.15%
Family Office
0.13%
Other
12.79%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
3494
311.59M
81.48%
-5.78M
2025Q2
3464
329.22M
86.11%
-1.59M
2025Q1
3477
331.34M
86.70%
+478.07K
2024Q4
3392
326.31M
85.52%
-6.25M
2024Q3
3219
327.28M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.55M
2023Q4
3047
327.61M
86.24%
+19.84M
2023Q3
2938
324.92M
85.54%
+14.80M
2023Q2
2898
325.04M
85.60%
+10.05M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
33.35M
8.72%
+437.93K
+1.33%
Jun 30, 2025
Brown (John W)
20.06M
5.25%
--
--
Feb 28, 2025
Greenleaf Trust
16.69M
4.37%
-427.58K
-2.50%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.08M
4.21%
-503.14K
-3.03%
Jun 30, 2025
State Street Investment Management (US)
14.96M
3.91%
+150.20K
+1.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
11.39M
2.98%
-237.74K
-2.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
7.39M
1.93%
+79.65K
+1.09%
Jun 30, 2025
JP Morgan Asset Management
7.37M
1.93%
-98.87K
-1.32%
Jun 30, 2025
AllianceBernstein L.P.
5.60M
1.46%
+4.22M
+307.57%
Jun 30, 2025
Capital Research Global Investors
6.77M
1.77%
-98.16K
-1.43%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Jensen Quality Growth ETF
6.01%
iShares U.S. Medical Devices ETF
4.17%
AdvisorShares Focused Equity ETF
3.62%
Gabelli Growth Innovators ETF
3%
Global X Aging Population ETF
2.85%
Hennessy Sustainable ETF
2.77%
Knowledge Leaders Developed World ETF
2.73%
Health Care Select Sector SPDR Fund
2.51%
Proshares Ultra Health Care
2.42%
iShares U.S. Healthcare ETF
2.4%
View more
Jensen Quality Growth ETF
Proportion6.01%
iShares U.S. Medical Devices ETF
Proportion4.17%
AdvisorShares Focused Equity ETF
Proportion3.62%
Gabelli Growth Innovators ETF
Proportion3%
Global X Aging Population ETF
Proportion2.85%
Hennessy Sustainable ETF
Proportion2.77%
Knowledge Leaders Developed World ETF
Proportion2.73%
Health Care Select Sector SPDR Fund
Proportion2.51%
Proshares Ultra Health Care
Proportion2.42%
iShares U.S. Healthcare ETF
Proportion2.4%
Dividend
A total of
5.22B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Aug 07, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Oct 31, 2025 going ex on Sep 30, 2025
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 08, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Jul 31, 2025 going ex on Jun 30, 2025
Jun 30, 2025
Jul 31, 2025
Jun 30, 2025
Feb 05, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 05, 2023
SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 31, 2024
Dec 28, 2023
Aug 02, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Oct 31, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 10, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 31, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 31, 2023
Jun 29, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Stryker Corp?
The top five shareholders of Stryker Corp are:
The Vanguard Group, Inc. holds 33.35M shares, accounting for 8.72% of the total shares.
Brown (John W) holds 20.06M shares, accounting for 5.25% of the total shares.
Greenleaf Trust holds 16.69M shares, accounting for 4.37% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 16.08M shares, accounting for 4.21% of the total shares.
State Street Investment Management (US) holds 14.96M shares, accounting for 3.91% of the total shares.
The Vanguard Group, Inc. holds 33.35M shares, accounting for 8.72% of the total shares.
Brown (John W) holds 20.06M shares, accounting for 5.25% of the total shares.
Greenleaf Trust holds 16.69M shares, accounting for 4.37% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 16.08M shares, accounting for 4.21% of the total shares.
State Street Investment Management (US) holds 14.96M shares, accounting for 3.91% of the total shares.
What are the top three shareholder types of Stryker Corp?
The top three shareholder types of Stryker Corp are:
The Vanguard Group, Inc.
Brown (John W)
Greenleaf Trust
The Vanguard Group, Inc.
Brown (John W)
Greenleaf Trust
How many institutions hold shares of Stryker Corp (SYK)?
As of 2025Q3, 3494 institutions hold shares of Stryker Corp, with a combined market value of approximately 311.59M, accounting for 81.48% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -4.63%.
What is the biggest source of revenue for Stryker Corp?
In FY2025Q2, the Medical business generated the highest revenue for Stryker Corp, amounting to 990.00M and accounting for 16.44% of total revenue.
